{"id":"https://openalex.org/W72795671","doi":null,"title":"A pharmacokinetic approach to model-guided design of infliximab schedules in ulcerative colitis patients.","display_name":"A pharmacokinetic approach to model-guided design of infliximab schedules in ulcerative colitis patients.","alternate_titles":[],"publication_year":2015,"publication_date":"2015-03-01","ids":{"openalex":"https://openalex.org/W72795671","mag":"72795671","pmid":"https://pubmed.ncbi.nlm.nih.gov/25733037"},"language":"en","primary_location":{"id":"pmid:25733037","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25733037","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista espanola de enfermedades digestivas","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W72795671"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059689286","display_name":"Alejandro P\u00e9rez\u2010Pitarch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alejandro P\u00e9rez-Pitarch","raw_affiliation_strings":["Universidad de Valencia, Valencia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad de Valencia, Valencia","institution_ids":["https://openalex.org/I16097986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075480861","display_name":"Rafael Ferriols\u2010Lisart","orcid":"https://orcid.org/0000-0003-0241-6491","observed_orcids":["https://orcid.org/0000-0003-0241-6491"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rafael Ferriols-Lisart","raw_affiliation_strings":["Universidad de Valencia, Valencia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad de Valencia, Valencia","institution_ids":["https://openalex.org/I16097986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006620492","display_name":"Manuel Al\u00f3s Almi\u00f1ana","orcid":"https://orcid.org/0000-0002-7527-4319","observed_orcids":["https://orcid.org/0000-0002-7527-4319"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuel Al\u00f3s-Almi\u00f1ana","raw_affiliation_strings":["Universidad de Valencia, Valencia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad de Valencia, Valencia","institution_ids":["https://openalex.org/I16097986"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086867036","display_name":"Miguel M\u00ednguez","orcid":"https://orcid.org/0000-0003-0148-5938","observed_orcids":["https://orcid.org/0000-0003-0148-5938"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel M\u00ednguez-P\u00e9rez","raw_affiliation_strings":["Universidad de Valencia, Valencia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad de Valencia, Valencia","institution_ids":["https://openalex.org/I16097986"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I16097986"],"apc_list":null,"apc_paid":null,"fwci":1.7203,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.82790194,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"107","issue":"3","first_page":"137","last_page":"142"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.02290000021457672,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":1.0},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/dosing-schedule-optimization","display_name":"dosing schedule optimization","score":0.7229999899864197},{"id":"https://openalex.org/keywords/pharmacokinetic-modeling","display_name":"pharmacokinetic modeling","score":0.6510000228881836},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.7369999885559082},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.6290000081062317},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.7149999737739563},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.5019999742507935},{"id":"https://openalex.org/keywords/monte-carlo-simulation","display_name":"Monte Carlo simulation","score":0.5630000233650208},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.9584567546844482},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8347652554512024},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.7963674664497375},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7589873671531677},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.727897047996521},{"id":"https://openalex.org/C2910800852","wikidata":"https://www.wikidata.org/wiki/Q7846541","display_name":"Trough Concentration","level":3,"score":0.6891683340072632},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5419931411743164},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49232780933380127},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4055064618587494},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32326996326446533},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.15364491939544678},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.15077948570251465},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003093","descriptor_name":"Colitis, Ulcerative","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003093","descriptor_name":"Colitis, Ulcerative","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005765","descriptor_name":"Gastrointestinal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005765","descriptor_name":"Gastrointestinal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005765","descriptor_name":"Gastrointestinal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009010","descriptor_name":"Monte Carlo Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015233","descriptor_name":"Models, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:25733037","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25733037","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista espanola de enfermedades digestivas","raw_type":"Journal Article"},{"id":"pmh:oai:scielo:S1130-01082015000300003","doi":null,"is_oa":false,"landing_page_url":"http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1130-01082015000300003","pdf_url":null,"source":{"id":"https://openalex.org/S4306402135","display_name":"Scientific Electronic library online (Sciences Carlos III Health Institute)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801357902","host_organization_name":"Instituto de Salud Carlos III","host_organization_lineage":["https://openalex.org/I2801357902"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Revista Espa\u00c3\u00b1ola de Enfermedades Digestivas v.107 n.3 2015","raw_type":"journal article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1968331553","https://openalex.org/W1981512015","https://openalex.org/W1985485048","https://openalex.org/W2000741779","https://openalex.org/W2003904406","https://openalex.org/W2040157712","https://openalex.org/W2043261411","https://openalex.org/W2044160586","https://openalex.org/W2083538444","https://openalex.org/W2094611674","https://openalex.org/W2102245241","https://openalex.org/W2102822061","https://openalex.org/W2103755206","https://openalex.org/W2106072130","https://openalex.org/W2108921569","https://openalex.org/W2119793607","https://openalex.org/W2136318351","https://openalex.org/W2146963207","https://openalex.org/W2333157326"],"related_works":["https://openalex.org/W4401793943","https://openalex.org/W4247006071","https://openalex.org/W4391161748","https://openalex.org/W2955532968","https://openalex.org/W2789348076","https://openalex.org/W3203334545","https://openalex.org/W2909905375","https://openalex.org/W2078580413","https://openalex.org/W2608036493","https://openalex.org/W2044160586"],"abstract_inverted_index":{"BACKGROUND:":[0],"Infliximab,":[1],"an":[2],"anti-tumour":[3],"necrosis":[4],"factor":[5],"approved":[6],"for":[7,87],"treatment":[8,28,231],"of":[9,26,36,44,52,75,133,142,157,174,211,229,232],"Crohn\u00b4s":[10],"disease":[11],"and":[12,97,103,108,115,125,128,151,160],"ulcerative":[13,58,245],"colitis,":[14],"is":[15,38],"administered":[16],"at":[17],"predefined":[18],"interdose":[19,131],"intervals.":[20],"On":[21],"insufficient":[22],"response":[23,37],"or":[24,34,145,177],"loss":[25,35],"response,":[27],"can":[29],"be":[30,199],"intensified.":[31],"The":[32],"lack":[33],"likely":[39],"related":[40],"to":[41,121,136,165,169,198],"complex":[42],"pharmacokinetics":[43],"infliximab.":[45],"AIMS:":[46],"To":[47],"explore":[48],"optimal":[49],"dosing":[50,85,202],"strategies":[51,86],"infliximab":[53,235],"in":[54],"treatment-na\u00efve":[55,77],"patients":[56,78,213,243],"with":[57,207,234,244],"colitis":[59,233],"through":[60],"predictive":[61],"Monte":[62],"Carlo":[63],"simulations":[64],"based":[65],"on":[66,92,100],"a":[67,129,138,154,171,208,237],"validated":[68],"population":[69,74],"PK":[70],"model.":[71],"METHODS:":[72],"A":[73],"2,000":[76],"was":[79,205],"generated":[80],"by":[81,236],"Montecarlo":[82],"simulation.":[83],"Six":[84],"maintenance":[88,230],"therapy":[89],"were":[90],"simulated":[91],"this":[93],"population.":[94],"Strategies":[95,113,149,182],"1":[96,191,216],"2":[98],"consisted":[99],"5":[101,143,150,158,175,196],"mg/kg":[102,105,159],"6":[104,146,152,178],"doses,":[106,119],"respectively,":[107],"8":[109,134],"weeks":[110,135],"inter-dose":[111,162],"interval.":[112],"3":[114],"4":[116],"used":[117,153],"Individualized":[118],"adjusted":[120,164],"albumin":[122],"level,":[123],"sex":[124],"body":[126],"weight,":[127],"fix":[130,155],"interval":[132],"achieve":[137,170],"target":[139,172],"trough":[140,185],"concentration":[141],"mg/L":[144,176],"mg/L,":[147,179],"respectively.":[148,180],"dose":[156],"individualized":[161],"intervals,":[163],"the":[166,200],"same":[167],"covariates,":[168],"concentration,":[173],"RESULTS:":[181],"2-6":[183],"reached":[184],"levels":[186],"statistically":[187],"higher":[188,209,224],"than":[189,214],"strategy":[190,215],"(p":[192],"<":[193],"0.05).":[194],"Strategy":[195],"proved":[197],"best":[201],"strategy.":[203],"It":[204],"associated":[206],"proportion":[210],"responder":[212],"(62":[217],"%":[218],"vs.":[219],"40":[220],"%)":[221],"without":[222],"reaching":[223],"peak":[225],"concentrations.":[226],"CONCLUSIONS:":[227],"Optimization":[228],"pharmacokinetic":[238],"approach":[239],"could":[240],"benefit":[241],"infliximab-naive":[242],"colitis.":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W72795671","counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
